Efficacy of Karpoor and Ajwain inhalation in COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/05/033499
- Lead Sponsor
- D Y Patil University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult ( >18 years) COVID-19 positive patients of either gender
2.Patients hospitalized in COVID-19 wards
3.Patients having SpO2 saturation of �90% on room air at enrolment
Exclusion Criteria
1.Patients on mechanical ventilation
2.Patients requiring nasal oxygen >6 litres/minutes
3.Patients with respiratory disorders, bronchial asthma, or COPD
4.Existing pulmonary tuberculosis
5.Patients admitted in ICU
6.Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to recovery (defined as the satisfaction of criteria�s 1, 2 or 3 of the 8-category ordinal scale for clinical improvement)Timepoint: End of study (up to 28 days)
- Secondary Outcome Measures
Name Time Method All-cause mortalityTimepoint: End of therapy;Mean oxygen saturation (SpO2)Timepoint: Recorded on daily basis after start of study therapy till patient is hospitalized or 28 days;Patient satisfaction score on a 5-point Likert scale of 1: Dissatisfied; 2: Neither satisfied nor dissatisfied; 3: Satisfied; 4: Somewhat satisfied; 5: Extremely satisfiedTimepoint: End of therapy;Percentage of patients requiring admission in ICUTimepoint: End of therapy;Percentage of patients requiring mechanical ventilationTimepoint: End of therapy;Percentage of patients requiring remdesivirTimepoint: End of therapy;Percentage of patients requiring tocilizumab/ Itolizumab/ bevacizumabTimepoint: End of therapy;Proportion of participants experiencing Treatment-Emergent Adverse Events (TEAE)Timepoint: End of study;Total duration of hospital stays (days)Timepoint: End of therapy